A Putative "hepitype" in the ATM Gene Associated with Chronic Lymphocytic Leukemia Risk

被引:4
|
作者
Martin-Guerrero, Idoia [1 ]
Enjuanes, Anna [2 ]
Richter, Julia [3 ,4 ]
Ammerpohl, Ole [3 ,4 ]
Colomer, Dolors [2 ]
Ardanaz, Maite [5 ]
Marco, Fernando [6 ]
Salas, Antonio [7 ,8 ]
Campo, Elias [2 ]
Siebert, Reiner [3 ,4 ]
Garcia-Orad, Africa [1 ]
机构
[1] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Leioa 48940, Bizkaia, Spain
[2] Univ Barcelona, Hosp Clin, Dept Anat Pathol, Inst Invest Biomed August Pi & Sunyer,Hematopatho, Barcelona, Spain
[3] Univ Kiel, Inst Human Genet, Kiel, Germany
[4] Univ Hosp Schleswig Holstein, Campus Kiel, Germany
[5] Hosp Txagorritxu, Vitoria, Alava, Spain
[6] Hosp Basurto, Bilbao, Vizcaya, Spain
[7] Univ Santiago Compostela, Fac Med, Inst Med Legal, Unidade Xenet, Galicia, Spain
[8] Univ Santiago Compostela, Fac Med, Dept Anat Patolox Ciencias Forenses, Galicia, Spain
关键词
DNA METHYLATION; DOWN-REGULATION; BREAST-CANCER; VARIANTS; CELL; GENOME; HYPERMETHYLATION; HAPLOTYPES; LYMPHOMA; TRANSCRIPTION;
D O I
10.1002/gcc.20912
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chronic lymphocytic leukemia (CLL) cells are characterized by several chromosomal lesions. Some of these aberrations imply chromosome breaks as a result of unrepaired double strand breaks (DSBs) in the DNA. The ATM (ataxia telangiectasia-mutated) protein is the principal integrator of cellular responses to DSBs. ATM deletion is also an adverse prognostic factor in CLL. Taking this into account, we evaluated if genetic and/or epigenetic variation in the ATM gene may modulate the individual susceptibility to develop CLL. Our case-control association study was performed in a large Spanish population of 1,503 individuals, including 742 patients with CLL and 761 controls. We identified one haplotype within the ATM gene that confers an increased risk of CLL development (OR = 1.33; 95% Cl: 1.10-1.60). Two polymorphisms of this ATM haplotype eliminated one CpG site each in Introns 15 and 61, causing changes in DNA methylation pattern. These data provide the first evidence for the existence of a putative "hepitype" in the ATM gene associated with CLL risk. (C) 2011 Wiley-Liss, Inc.
引用
收藏
页码:887 / 895
页数:9
相关论文
共 50 条
  • [1] Rare Germline ATM Variants Influence the Development of Chronic Lymphocytic Leukemia
    Lampson, Benjamin L.
    Gupta, Aditi
    Tyekucheva, Svitlana
    Mashima, Kiyomi
    Petrackova, Anna
    Wang, Zixu
    Wojciechowska, Natalia
    Shaughnessy, Conner J.
    Baker, Peter O.
    Fernandes, Stacey M.
    Shupe, Samantha
    Machado, John-Hanson
    Fardoun, Rayan
    Kim, Annette S.
    Brown, Jennifer R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (05) : 1116 - +
  • [2] Occurrence of associated tumours in chronic lymphocytic leukemia
    Laszlo, Szerafin
    Janos, Jako
    Lorant, Varju
    ORVOSI HETILAP, 2016, 157 (44) : 1752 - 1756
  • [3] microRNA and Chronic Lymphocytic Leukemia
    Giza, Dana Elena
    Calin, George A.
    MICRORNA: CANCER: FROM MOLECULAR BIOLOGY TO CLINICAL PRACTICE, 2015, 889 : 23 - 40
  • [4] The Endothelial Nitric Oxide Synthase Gene Variants as a Risk Factor for Chronic Lymphocytic Leukemia
    Pehlivan, Mustafa
    Tomatir, Ayse G.
    Nursal, Aye F.
    Sahin, Handan H.
    Pehlivan, Sacide
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2017, 27 (02): : 85 - 90
  • [5] KIBRA gene methylation is associated with unfavorable biological prognostic parameters in chronic lymphocytic leukemia
    Shinawi, Thoraia
    Hill, Victoria
    Dagklis, Antonis
    Baliakas, Panagiotis
    Stamatopoulos, Kostas
    Agathanggelou, Angleo
    Stankovic, Tanja
    Maher, Eamonn R.
    Ghia, Paolo
    Latif, Farida
    EPIGENETICS, 2012, 7 (03) : 211 - 215
  • [6] Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia
    Huang, Di
    Ovcharenko, Ivan
    BMC GENOMICS, 2017, 18
  • [7] No evidence for DNA methylation of the ATM promoter CpG island in chronic lymphocytic leukemia
    Mikeska, Thomas
    Carney, Dennis A.
    Seymour, John F.
    Dobrovic, Alexander
    LEUKEMIA & LYMPHOMA, 2012, 53 (07) : 1420 - 1422
  • [8] Extensive Promoter DNA Hypermethylation and Hypomethylation Is Associated with Aberrant MicroRNA Expression in Chronic Lymphocytic Leukemia
    Baer, Constance
    Claus, Rainer
    Frenzel, Lukas P.
    Zucknick, Manuela
    Park, Yoon Jung
    Gu, Lei
    Weichenhan, Dieter
    Fischer, Martina
    Pallasch, Christian Philipp
    Herpel, Esther
    Rehli, Michael
    Byrd, John C.
    Wendtner, Clemens-Martin
    Plass, Christoph
    CANCER RESEARCH, 2012, 72 (15) : 3775 - 3785
  • [9] Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic Leukemia
    Ojha, Juhi
    Codd, Veryan
    Nelson, Christopher P.
    Samani, Nilesh J.
    Smirnov, Ivan V.
    Madsen, Nils R.
    Hansen, Helen M.
    de Smith, Adam J.
    Bracci, Paige M.
    Wiencke, John K.
    Wrensch, Margaret R.
    Wiemels, Joseph L.
    Walsh, Kyle M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (07) : 1043 - 1049
  • [10] Molecular characterization of Novel ATM fusions in chronic lymphocytic leukemia and T-cell prolymphocytic leukemia
    Kanagal-Shamanna, Rashmi
    Bao, Haiyan
    Kearney, Hutton
    Smoley, Stephanie
    Tang, Zhenya
    Luthra, Rajyalakshmi
    Yang, Hui
    Zhang, Shanshan
    Lin, Pei
    Wu, Depei
    Medeiros, L. Jeffrey
    Lu, Xinyan
    LEUKEMIA & LYMPHOMA, 2022, 63 (04) : 865 - 875